These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22246293)

  • 1. Novel pharmacological chaperones that correct phenylketonuria in mice.
    Santos-Sierra S; Kirchmair J; Perna AM; Reiss D; Kemter K; Röschinger W; Glossmann H; Gersting SW; Muntau AC; Wolber G; Lagler FB
    Hum Mol Genet; 2012 Apr; 21(8):1877-87. PubMed ID: 22246293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Lagler FB; Gersting SW; Zsifkovits C; Steinbacher A; Eichinger A; Danecka MK; Staudigl M; Fingerhut R; Glossmann H; Muntau AC
    Biochem Pharmacol; 2010 Nov; 80(10):1563-71. PubMed ID: 20705059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo.
    Gersting SW; Lagler FB; Eichinger A; Kemter KF; Danecka MK; Messing DD; Staudigl M; Domdey KA; Zsifkovits C; Fingerhut R; Glossmann H; Roscher AA; Muntau AC
    Hum Mol Genet; 2010 May; 19(10):2039-49. PubMed ID: 20179079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylalanine hydroxylase misfolding and pharmacological chaperones.
    Underhaug J; Aubi O; Martinez A
    Curr Top Med Chem; 2012; 12(22):2534-45. PubMed ID: 23339306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response.
    Staudigl M; Gersting SW; Danecka MK; Messing DD; Woidy M; Pinkas D; Kemter KF; Blau N; Muntau AC
    Hum Mol Genet; 2011 Jul; 20(13):2628-41. PubMed ID: 21527427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.
    Thöny B; Ding Z; Martínez A
    FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency.
    Ponzone A; Porta F; Mussa A; Alluto A; Ferraris S; Spada M
    Metabolism; 2010 May; 59(5):645-52. PubMed ID: 19913839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
    Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations.
    Pey AL; Pérez B; Desviat LR; Martínez MA; Aguado C; Erlandsen H; Gámez A; Stevens RC; Thórólfsson M; Ugarte M; Martínez A
    Hum Mutat; 2004 Nov; 24(5):388-99. PubMed ID: 15459954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylalanine hydroxylase: function, structure, and regulation.
    Flydal MI; Martinez A
    IUBMB Life; 2013 Apr; 65(4):341-9. PubMed ID: 23457044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of BH4 -responsive hyperphenylalaninemia--as it occurs in the ENU1/2 genetic mouse model.
    Sarkissian CN; Ying M; Scherer T; Thöny B; Martinez A
    Hum Mutat; 2012 Oct; 33(10):1464-73. PubMed ID: 22644647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.
    Muntau AC; Röschinger W; Habich M; Demmelmair H; Hoffmann B; Sommerhoff CP; Roscher AA
    N Engl J Med; 2002 Dec; 347(26):2122-32. PubMed ID: 12501224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.
    Heintz C; Cotton RG; Blau N
    Hum Mutat; 2013 Jul; 34(7):927-36. PubMed ID: 23559577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of wild-type and mutant phenylalanine hydroxylase and its regulation by phenylalanine and tetrahydrobiopterin at physiological and pathological concentrations: an isothermal titration calorimetry study.
    Pey AL; Martinez A
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S43-53. PubMed ID: 15936235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New protein structures provide an updated understanding of phenylketonuria.
    Jaffe EK
    Mol Genet Metab; 2017 Aug; 121(4):289-296. PubMed ID: 28645531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability.
    Gersting SW; Kemter KF; Staudigl M; Messing DD; Danecka MK; Lagler FB; Sommerhoff CP; Roscher AA; Muntau AC
    Am J Hum Genet; 2008 Jul; 83(1):5-17. PubMed ID: 18538294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Zurflüh MR; Zschocke J; Lindner M; Feillet F; Chery C; Burlina A; Stevens RC; Thöny B; Blau N
    Hum Mutat; 2008 Jan; 29(1):167-75. PubMed ID: 17935162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias.
    Blau N
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1207-18. PubMed ID: 23705856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients.
    Utz JR; Lorentz CP; Markowitz D; Rudser KD; Diethelm-Okita B; Erickson D; Whitley CB
    Mol Genet Metab; 2012 Feb; 105(2):193-7. PubMed ID: 22112818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of tetrahydrobiopterin (BH(4))-responsiveness and spontaneous phenylalanine reduction in a phenylalanine hydroxylase deficiency population.
    Tansek MZ; Groselj U; Murko S; Kobe H; Lampret BR; Battelino T
    Mol Genet Metab; 2012 Sep; 107(1-2):37-42. PubMed ID: 22917871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.